Clinical Trial Update: Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemoradiation with durvalumab followed by durvalumab maintenance in limited-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Samsung Medical Center | Conditions: Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN